Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achieve Life Sciences Inc ACHV

Healthcare Biotechnology
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of... see more

Recent & Breaking News (NDAQ:ACHV)

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

GlobeNewswire 1 day ago

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

GlobeNewswire April 11, 2024

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

GlobeNewswire March 28, 2024

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

GlobeNewswire March 20, 2024

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

GlobeNewswire March 14, 2024

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire March 6, 2024

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

GlobeNewswire February 29, 2024

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire February 29, 2024

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

GlobeNewswire December 13, 2023

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire December 11, 2023

Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

GlobeNewswire November 9, 2023

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

GlobeNewswire October 26, 2023

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire October 3, 2023

Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting

GlobeNewswire September 11, 2023

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire September 7, 2023

Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update

GlobeNewswire August 14, 2023

Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast

GlobeNewswire August 1, 2023

Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting

GlobeNewswire July 18, 2023

Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)

GlobeNewswire July 11, 2023

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire June 6, 2023